Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Viral immune modulators perturb the human molecular network by common and unique strategies.

Pichlmair A, Kandasamy K, Alvisi G, Mulhern O, Sacco R, Habjan M, Binder M, Stefanovic A, Eberle CA, Goncalves A, Bürckstümmer T, Müller AC, Fauster A, Holze C, Lindsten K, Goodbourn S, Kochs G, Weber F, Bartenschlager R, Bowie AG, Bennett KL, Colinge J, Superti-Furga G.

Nature. 2012 Jul 26;487(7408):486-90. doi: 10.1038/nature11289.

PMID:
22810585
2.

Viral evasion mechanisms of early antiviral responses involving regulation of ubiquitin pathways.

Rajsbaum R, García-Sastre A.

Trends Microbiol. 2013 Aug;21(8):421-9. doi: 10.1016/j.tim.2013.06.006. Epub 2013 Jul 11. Review.

3.

Virus-human cell interactomes.

Tafforeau L, Rabourdin-Combe C, Lotteau V.

Methods Mol Biol. 2012;812:103-20. doi: 10.1007/978-1-61779-455-1_6.

PMID:
22218856
4.

Host cellular signaling induced by influenza virus.

Dai X, Zhang L, Hong T.

Sci China Life Sci. 2011 Jan;54(1):68-74. doi: 10.1007/s11427-010-4116-z. Epub 2011 Jan 21.

PMID:
21253874
5.

Viral evasion and subversion of pattern-recognition receptor signalling.

Bowie AG, Unterholzner L.

Nat Rev Immunol. 2008 Dec;8(12):911-22. doi: 10.1038/nri2436. Review.

PMID:
18989317
6.

Structure and Function of Viral Deubiquitinating Enzymes.

Bailey-Elkin BA, Knaap RCM, Kikkert M, Mark BL.

J Mol Biol. 2017 Nov 10;429(22):3441-3470. doi: 10.1016/j.jmb.2017.06.010. Epub 2017 Jun 16. Review.

PMID:
28625850
7.

Recent advances on viral manipulation of NF-κB signaling pathway.

Zhao J, He S, Minassian A, Li J, Feng P.

Curr Opin Virol. 2015 Dec;15:103-11. doi: 10.1016/j.coviro.2015.08.013. Epub 2015 Sep 15. Review.

8.

The interferon antiviral response: from viral invasion to evasion.

Grandvaux N, tenOever BR, Servant MJ, Hiscott J.

Curr Opin Infect Dis. 2002 Jun;15(3):259-67. Review.

PMID:
12015460
9.

Manipulation of viral infection by deubiquitinating enzymes: new players in host-virus interactions.

Gu Z, Shi W.

Future Microbiol. 2016 Oct;11:1435-1446. Epub 2016 Oct 27. Review.

PMID:
27785925
10.

Viral and host strategies to take advantage of the innate immune response.

Zhang Y, Hinojosa ME, Yoo N, Holtzman MJ.

Am J Respir Cell Mol Biol. 2010 Nov;43(5):507-10. doi: 10.1165/rcmb.2009-0213ED. No abstract available.

PMID:
20971885
11.

Viral deubiquitinases: role in evasion of anti-viral innate immunity.

Kumari P, Kumar H.

Crit Rev Microbiol. 2018 May;44(3):304-317. doi: 10.1080/1040841X.2017.1368999. Epub 2017 Sep 8. Review.

PMID:
28885059
12.

Innate immune response and viral interference strategies developed by human herpesviruses.

Vandevenne P, Sadzot-Delvaux C, Piette J.

Biochem Pharmacol. 2010 Dec 15;80(12):1955-72. doi: 10.1016/j.bcp.2010.07.001. Epub 2010 Jul 8. Review.

13.

Murine gammaherpesvirus 68 encoding open reading frame 11 targets TANK binding kinase 1 to negatively regulate the host type I interferon response.

Kang HR, Cheong WC, Park JE, Ryu S, Cho HJ, Youn H, Ahn JH, Song MJ.

J Virol. 2014 Jun;88(12):6832-46. doi: 10.1128/JVI.03460-13. Epub 2014 Apr 2.

14.

An arms race: innate antiviral responses and counteracting viral strategies.

Schröder M, Bowie AG.

Biochem Soc Trans. 2007 Dec;35(Pt 6):1512-4. Review.

PMID:
18031256
15.

Putting the brakes on the anti-viral response: negative regulators of type I interferon (IFN) production.

Richards KH, Macdonald A.

Microbes Infect. 2011 Apr;13(4):291-302. doi: 10.1016/j.micinf.2010.12.007. Epub 2011 Jan 20. Review.

PMID:
21256242
16.

Quelling an innate response to dsRNA.

Ogden KM, Prasad BV.

Oncotarget. 2015 Oct 6;6(30):28535-6. doi: 10.18632/oncotarget.5110. No abstract available.

17.

Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins.

Rozenblatt-Rosen O, Deo RC, Padi M, Adelmant G, Calderwood MA, Rolland T, Grace M, Dricot A, Askenazi M, Tavares M, Pevzner SJ, Abderazzaq F, Byrdsong D, Carvunis AR, Chen AA, Cheng J, Correll M, Duarte M, Fan C, Feltkamp MC, Ficarro SB, Franchi R, Garg BK, Gulbahce N, Hao T, Holthaus AM, James R, Korkhin A, Litovchick L, Mar JC, Pak TR, Rabello S, Rubio R, Shen Y, Singh S, Spangle JM, Tasan M, Wanamaker S, Webber JT, Roecklein-Canfield J, Johannsen E, Barabási AL, Beroukhim R, Kieff E, Cusick ME, Hill DE, Münger K, Marto JA, Quackenbush J, Roth FP, DeCaprio JA, Vidal M.

Nature. 2012 Jul 26;487(7408):491-5. doi: 10.1038/nature11288.

18.

A logical model of HIV-1 interactions with the T-cell activation signalling pathway.

Oyeyemi OJ, Davies O, Robertson DL, Schwartz JM.

Bioinformatics. 2015 Apr 1;31(7):1075-83. doi: 10.1093/bioinformatics/btu787. Epub 2014 Nov 26.

PMID:
25431332
19.

Exploration of panviral proteome: high-throughput cloning and functional implications in virus-host interactions.

Yu X, Bian X, Throop A, Song L, Moral LD, Park J, Seiler C, Fiacco M, Steel J, Hunter P, Saul J, Wang J, Qiu J, Pipas JM, LaBaer J.

Theranostics. 2014 Jun 6;4(8):808-22. doi: 10.7150/thno.8255. eCollection 2014.

20.

System-level comparison of protein-protein interactions between viruses and the human type I interferon system network.

Navratil V, de Chassey B, Meyniel L, Pradezynski F, André P, Rabourdin-Combe C, Lotteau V.

J Proteome Res. 2010 Jul 2;9(7):3527-36. doi: 10.1021/pr100326j.

PMID:
20459142

Supplemental Content

Support Center